Marij J. Welters - Publications

Exploring the Immunomodulatory Effects of Fasting-Mimicking Diet in Healthy Individuals: A Pilot Study.

Journal: Nutrients

Published: June 05, 2026

Investigators' response.

Journal: Clinical and translational radiation oncology

Published: April 08, 2026

Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4+ T cell help.

Journal: Cell reports methods

Published: November 13, 2025

The local cellular response to Human Papillomavirus focuses on basal layer restoration as visualized in situ by specific cellular neighborhoods near infected cells.

Journal: Frontiers in immunology

Published: October 20, 2025

Rapid liquid biopsy assessment through gene profiling from the kidney biopsy transport medium: A technical validation and a proof-of-concept pilot study.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: September 24, 2025

Dynamic immune changes after bone marrow sparing VMAT in women with locally advanced cervical cancer treated with chemoradiotherapy.

Journal: Clinical and translational radiation oncology

Published: August 21, 2025

Single-cell spatial transcriptomics unravels cell states and ecosystems associated with clinical response to immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: February 25, 2025

TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study.

Journal: Nature communications

Published: February 10, 2025

Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma.

Journal: Journal for immunotherapy of cancer

Published: June 09, 2024

Blood based immune biomarkers associated with clinical frailty scale in older patients with melanoma receiving checkpoint inhibitor immunotherapy.

Journal: Immunity & ageing : I & A

Published: June 06, 2024

APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 20, 2024

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism.

Journal: The Journal of clinical investigation

Published: January 18, 2024